Practically every big U.S. city and most states would love to become the next hot biotech cluster. Having the cachet of a biotech haven helps attract bright scientists, new startups and, eventually, more tax revenue.
But amid the competition for biotech companies, some locations offer much better incentives than others. Thus, e-mail newsletter FierceBiotech is putting out a list of five emerging hot spots for biotech, to be published in full on Wednesday. The winners are, in alphabetical order: California, Maryland and its I-270 tech corridor, New Jersey, Singapore and Wisconsin.
Wisconsin makes the list based in part on a $375 million research facility the state is building at the University of Wisconsin-Madison. The state is also very aggressive in attracting biotech and medical device companies.